Page last updated: 2024-09-03

clofarabine and abt-199

clofarabine has been researched along with abt-199 in 1 studies

Compound Research Comparison

Studies
(clofarabine)
Trials
(clofarabine)
Recent Studies (post-2010)
(clofarabine)
Studies
(abt-199)
Trials
(abt-199)
Recent Studies (post-2010) (abt-199)
4241012801,4831501,469

Protein Interaction Comparison

ProteinTaxonomyclofarabine (IC50)abt-199 (IC50)
Apoptosis regulator Bcl-2Homo sapiens (human)0.0392
Bcl-2-like protein 1Homo sapiens (human)0.0667
Induced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)0.0044
Aspartyl/asparaginyl beta-hydroxylaseHomo sapiens (human)1.445
Bcl-2-related protein A1Homo sapiens (human)0.0044

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hosono, N; Negoro, E; Nishi, R; Okura, M; Shigemi, H; Yamauchi, T1

Other Studies

1 other study(ies) available for clofarabine and abt-199

ArticleYear
Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine.
    BMC cancer, 2020, Oct-12, Volume: 20, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Clofarabine; Cytarabine; Flavonoids; Humans; Leukemia, Myeloid, Acute; Piperidines; Sulfonamides

2020